Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Sechenov University, Moscow, Russia.
Andrology. 2022 Sep;10(6):1047-1056. doi: 10.1111/andr.13159. Epub 2022 Feb 19.
The COVID-19 pandemic has led the international community to conduct extensive research into potential negative effects of the disease on multiple organs and systems in the human body. One of the most discussed areas is potential of the virus to compromise the testicular function. However, the lack of prospective studies on this topic makes it impossible to draw reliable conclusions on whether the disease affects the male reproductive system and, if so, to what extent.
The current trial is aimed at investigating the effect of SARS-CoV-2 on the testicular function, hormone levels and determining the extent of impact on spermatogenesis and damage to testicular tissue.
This prospective study included healthy controls and cases of patients suffering from viral pneumonia based on chest computed tomography (CT) and a positive SARS-CoV-2 throat swab exhibited moderate symptoms (World Health Organization (WHO) classification). Epidemiological, clinical, laboratory and ultrasound data were collected. A semen analysis was performed in cases during their hospital stay and 3 months after the discharge home. We also assessed the testicles obtained during autopsies of patients who died of COVID-19 (n = 20).
A total of 88 participants were included (44 controls and 44 cases). Blood testosterone levels were significantly decreased in 27.3% of the cases (12/44). The mean level (7.3±2.7 nmol/L) was lower than that in the healthy controls (13.5±5.2 nmol/L, p < 0.001). An increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) was also detected compared to the healthy controls (p = 0.04 and p = 0.002). The semen analysis revealed decreased motility in COVID-19 patients (p = 0.001), and a higher number of immobile sperm (during COVID-19: 58.8% and at 3 months 47.4%, p = 0.005). All parameters returned to normal at 3 months after discharge. Direct mixed agglutination reaction (MAR) test at 3 months showed an increase of Ig A (p = 0.03). In the majority of autopsies (18/20), structural disorders of the testicular tissue, with signs of damage to germ cells were observed.
COVID-19 and its management strategies significantly affect male hormone levels and sperm quality at the onset of the disease. Postmortem examination of testicular tissue confirmed inflammation and viral infiltration of the testicles. However, in patients with moderate to severe disease, the studied parameters of the testicular function returned to normal values within 3 months.
COVID-19 大流行促使国际社会广泛研究该疾病对人体多个器官和系统的潜在负面影响。讨论最多的领域之一是病毒损害睾丸功能的可能性。然而,由于缺乏关于这一主题的前瞻性研究,因此无法就该疾病是否影响男性生殖系统以及影响程度如何得出可靠的结论。
本试验旨在研究 SARS-CoV-2 对睾丸功能、激素水平的影响,并确定对精子发生和睾丸组织损伤的影响程度。
这项前瞻性研究包括健康对照组和基于胸部计算机断层扫描(CT)的病毒性肺炎患者病例,以及表现出中度症状的 SARS-CoV-2 咽拭子阳性病例(世界卫生组织(WHO)分类)。收集了流行病学、临床、实验室和超声数据。在住院期间和出院后 3 个月对病例进行精液分析。我们还评估了 COVID-19 死亡患者(n=20)尸检获得的睾丸。
共纳入 88 名参与者(44 名对照组和 44 名病例)。病例中有 27.3%(12/44)的患者血液睾酮水平明显下降。平均水平(7.3±2.7 nmol/L)低于健康对照组(13.5±5.2 nmol/L,p<0.001)。与健康对照组相比,还检测到黄体生成素(LH)和卵泡刺激素(FSH)的升高(p=0.04 和 p=0.002)。精液分析显示 COVID-19 患者的运动能力下降(p=0.001),不动精子数量增加(COVID-19 期间:58.8%,3 个月后:47.4%,p=0.005)。出院后 3 个月所有参数均恢复正常。3 个月时直接混合凝集反应(MAR)试验显示 IgA 增加(p=0.03)。在大多数尸检中(18/20),观察到睾丸组织结构紊乱,有生殖细胞损伤的迹象。
COVID-19 及其管理策略会在疾病发作时显著影响男性激素水平和精子质量。睾丸组织的尸检检查证实了炎症和病毒浸润。然而,在中重度疾病患者中,睾丸功能的研究参数在 3 个月内恢复正常。